Added to YB: 2021-06-08
Pitch date: 2021-06-08
HRTX [bullish]
Heron Therapeutics, Inc.
-90.3%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.
Market Cap
$201.7M
Pitch Price
$14.13
Price Target
N/A
Dividend
N/A
EV/EBITDA
51.18
P/E
-12.79
EV/Sales
1.90
Sector
Biotechnology
Category
N/A
Show full summary:
HERON THERAPEUTICS INC HRTX
A summary for this pitch has not been created yet.
Read full article (0 min)